<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Leukemia
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/leukemia" data-history-node-id="1029" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div class="WordSection1">
        <div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
         <p style="border:none; padding:0in">
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <b>
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 Acute Leukemia - Robert Corty
                </span>
               </span>
              </b>
             </span>
            </span>
           </span>
          </span>
         </p>
        </div>
        <p>
         <span style="page:WordSection1">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Background
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Unchecked proliferation of WBC precursors causes marrow failure
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Can be fatal in days to months
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Pt’s with suspected acute leukemia require hospitalization for urgent diagnosis & treatment
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 APL has both the highest in-hospital mortality & highest cure rate
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Types:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="background:white">
                   <span style="font-family:Palatino">
                    <span style="color:black">
                     AML
                    </span>
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    = Acute Myeloid Leukemia – most common
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="background:white">
                   <span style="font-family:Palatino">
                    <span style="color:black">
                     APL
                    </span>
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    = acute promyelocytic leukemia
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Wingdings">
                   <span style="color:black">
                    
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    translocation (15;17)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection1">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="background:white">
                   <span style="font-family:Palatino">
                    <span style="color:black">
                     ALL
                    </span>
                   </span>
                  </span>
                 </span>
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    = acute lymphocytic leukemia
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection1">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Risk Factors:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    ionizing radiation
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    chemical exposures(e.g benzene)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    HIV
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    immunosuppression
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    myeloproliferative disorders
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection2">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    aplastic anemia
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    chemotherapy, specifically, alkylating agents and topoisomerase inhibitors
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
       </div>
       <p>
       </p>
       <p>
        <span style="page:WordSection3">
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Presentation
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </span>
       </p>
       <div class="WordSection3">
        <ul>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Leukocytosis, often blastocytosis: leukemia cutis, gingival hypertrophy, leukostasis
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Functional Leukopenia, often neutropenia: recurrent infections
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Anemia: fatigue, pallor, dyspnea
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Thrombocytopenia: gingival bleeding, epistaxis, petechiae, ecchymoses, menorrhagia
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Extramedullary hematopoiesis: splenomegaly, hepatomegaly, lymphadenopathy
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p>
        </p>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Evaluation
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Diagnosis of acute leukemia requires one of the following:
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    20% blasts in peripheral blood
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    > 20% blasts in bone marrow biopsy
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Any pathognomonic cytogenetic abnormality of t(8;21), inv(16), t(15;17)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Check for the presence of these time-sensitive conditions.
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    DIC – check fibrinogen, PT, PTT, platelets
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    TLS – check uric acid, phosphate, LDH, K+
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Neutropenic fever – check temp, neutrophil count
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Leukostasis  (see below)
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Presumptive APL – promyelocytes on diff, DIC or Auer rods on smear
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Confirm if peripheral flow cytometry ordered/in process
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <ul>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Use hematology admission order set
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Set RBC and Plt transfusion thresholds
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Order nurse-driven electrolyte repletion
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    ECG and TTE to establish pre-chemotherapy cardiac function
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Daily labs: CBC, TLS, DIC
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <b>
                  <span style="font-size:12.0pt">
                   <span style="font-family:Palatino">
                    <span style="color:black">
                     TLS prophylaxis
                    </span>
                   </span>
                  </span>
                 </b>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
        <p>
        </p>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Management
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Page heme fellow
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Discuss chemo plan and order double lumen PICC for reliable access
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    If findings suggest APL discuss starting ATRA
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Subspecialized lab tests: bone marrow biopsy, cytogenetics, FISH
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="tab-stops:9.0pt">
              <span style="font-family:Calibri,sans-serif">
               <span style="font-size:12.0pt">
                <span style="font-family:Palatino">
                 <span style="color:black">
                  Monitor for Common Complications/Emergencies: (see individual sections)
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    TLS, DIC, Febrile Neutropenia, Leukostasis
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
        <p>
        </p>
        <p>
         <span style="page:WordSection3">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Additional Information
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Obtain blood product consent on admission
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 APL Specific findings: promyelocytes on differential or Auer rods on smear
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection3">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Differentiation syndrome: promyelocytes differentiate
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Symptoms and signs: fever, SOB, Hypotn, peripheral edema, pleural effusion, AKI
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Diagnosis: No defined criteria.  If suspicious, discuss with hematology fellow
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
           <li>
            <span style="page:WordSection3">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Management:
                    <b>
                     steroids
                    </b>
                    .  If critically ill,
                    <b>
                     hold
                    </b>
                    <b>
                     ATRA
                    </b>
                    <b>
                     and
                    </b>
                    <b>
                     ATO
                    </b>
                    and consider
                    <b>
                     hydroxyurea
                    </b>
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
        </ul>
       </div>
       <p>
       </p>
       <div class="WordSection4">
        <p>
        </p>
        <div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
         <p style="border:none; padding:0in">
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:107%">
             <span style="font-family:Calibri,sans-serif">
              <b>
               <span style="font-size:12.0pt">
                <span style="line-height:107%">
                 <span style="font-family:Palatino">
                  Leukemia Treatment Overview
                 </span>
                </span>
               </span>
              </b>
             </span>
            </span>
           </span>
          </span>
         </p>
        </div>
        <ul>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 General strategy is to use “induction” chemo to try to induce clinicopathologic (as opposed to molecular) “remission”
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Defined as absence of symptoms, normal CBC, and < 5% blasts in bone marrow (on day 28)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Then waiting in hospital until neutrophil count > 500 (typically ~3 weeks)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 From there, bone marrow transplant (for high risk disease) or “consolidation” chemo for normal-risk or low-risk disease
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p style="margin-left:24px">
        </p>
        <p>
         <span style="page:WordSection4">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 AML
                </span>
               </span>
              </span>
             </b>
             <b>
             </b>
            </span>
           </span>
          </span>
         </span>
        </p>
        <p>
         <span style="page:WordSection4">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Induction
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Typical is “7+3” i.e. idrarubicin on days 1-3 and cytarabine on days 1-7
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 If therapy-related AML, MDS-related AML, or AML with cytogenetics similar to MDS, use “Vyxeos” which is liposomal daunorubicin and cytarabine on days 1, 3, and 5
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 If low-risk dz (t(8;21) or inv(16)), use cytarabine on days 1-7, and 3 days of low-dose daunorubicin + gemtuzumab-ozogamicin
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 There are other induction regimens that can be used depending on specific cytogenetics and patient frailty, which is beyond beyond the scope of the handbook
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p>
        </p>
        <p>
         <span style="page:WordSection4">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               <span style="color:black">
                Consolidation
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Typically  “HiDAC”(high-dose Ara-C – brand name for cytarabine)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
          <ul style="list-style-type:circle">
           <li>
            <span style="page:WordSection4">
             <span style="font-size:11pt">
              <span style="line-height:normal">
               <span style="tab-stops:9.0pt">
                <span style="font-family:Calibri,sans-serif">
                 <span style="font-size:12.0pt">
                  <span style="font-family:Palatino">
                   <span style="color:black">
                    Generally too toxic for pts with age > 60, so a dose reduction is used
                   </span>
                  </span>
                 </span>
                </span>
               </span>
              </span>
             </span>
            </span>
           </li>
          </ul>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 In the case of relapse, typical treatment is a different high-dose chemo and BMT if possible
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
        <p>
        </p>
        <p>
         <span style="page:WordSection4">
          <span style="font-size:11pt">
           <span style="line-height:normal">
            <span style="font-family:Calibri,sans-serif">
             <b>
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 ALL
                </span>
               </span>
              </span>
             </b>
            </span>
           </span>
          </span>
         </span>
        </p>
        <ul>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 Typical induction is “HyperCVAD” (hyper-fractionated cyclophosphamide, vincristine, doxorubicin (“A” due to trade name Adriamycin), and dexamethasone
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 If t(9;22) (known as Philadelphia chromosome), use tyrosine kinase inhibitor (TKI)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
         <li>
          <span style="page:WordSection4">
           <span style="font-size:11pt">
            <span style="line-height:normal">
             <span style="font-family:Calibri,sans-serif">
              <span style="font-size:12.0pt">
               <span style="font-family:Palatino">
                <span style="color:black">
                 If CD20+, use rituximab (requires CNS prophylaxis)
                </span>
               </span>
              </span>
             </span>
            </span>
           </span>
          </span>
         </li>
        </ul>
       </div>
       <p>
       </p>
       <p>
        <span style="font-size:11pt">
         <span style="line-height:normal">
          <span style="font-family:Calibri,sans-serif">
           <b>
            <span style="font-size:12.0pt">
             <span style="font-family:Palatino">
              <span style="color:black">
               Common Chemotherapy Regimens for Leukemia Encountered as Inpatient
              </span>
             </span>
            </span>
           </b>
          </span>
         </span>
        </span>
       </p>
       <table class="TableGrid3" style="width:354px; border-collapse:collapse; border:none" width="354">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Regimen</td>
      <td>Components</td>
      <td>Use</td>
    </tr>
    <tr>
      <td>7+3</td>
      <td>Cytarabine (Ara-C) x 7 d &amp; Anthracycline (e.g. idarubicin x3 d)</td>
      <td>AML induction</td>
    </tr>
    <tr>
      <td>Vyxeos</td>
      <td>Cytarabine + liposomal daunorubicin</td>
      <td>AML-MRC or t-AML</td>
    </tr>
    <tr>
      <td>CLAG-M</td>
      <td>Cladribine, cytarabine (Ara-C), Filgrastim (G-CSF), mitoxantrone</td>
      <td>AML induction (relapsed/refractory)</td>
    </tr>
    <tr>
      <td>HIDAC</td>
      <td>High-dose cytarabine</td>
      <td>AML consolidation</td>
    </tr>
    <tr>
      <td>ATRA</td>
      <td>All-trans retinoic acid given with arsenic trioxide (ATO)</td>
      <td>APL (APML)</td>
    </tr>
    <tr>
      <td>HyperCVAD/MA</td>
      <td>CVAD = Cyclophosphamide, vincristine, doxorubicin, dexamethasone MA = methotrexate/cytarabine (Given as alternating cycles)</td>
      <td>ALL</td>
    </tr>
    <tr>
      <td>R-CHOP</td>
      <td>Rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone</td>
      <td>NHL</td>
    </tr>
    <tr>
      <td>R-EPOCH</td>
      <td>Etoposide plus the drugs above (dosing is different)</td>
      <td>NHL</td>
    </tr>
    <tr>
      <td>ABVD</td>
      <td>Doxorubicin, bleomycin, vinblastine, dacarbazine</td>
      <td>HL</td>
    </tr>
  </tbody>
</table>
       </table>
       <p>
       </p>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>